Bausch & Lomb

Bausch & Lomb

Eye health products company.

Launch date
Employees
Market cap
$5.5b
Enterprise valuation
$9.9b (Public information from Sep 2024)
Bridgewater Township New Jersey (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2019202020212022202320242025
Revenues3.8b3.4b3.8b3.8b4.1b6.4b6.8b
% growth3 %(10 %)10 %-10 %54 %6 %
EBITDA1.0b750m785m457m601m--
% EBITDA margin26 %22 %21 %12 %14 %--
Profit298m(18.0m)182m6.0m(260m)--
% profit margin8 %(1 %)5 %-(6 %)--
R&D budget258m253m271m307m324m--
R&D % of revenue7 %7 %7 %8 %8 %--
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO

$8.7b

Acquisition
*
N/A

N/A

Post IPO Debt
Total Funding-

Recent News about Bausch & Lomb

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Bausch & Lomb

Edit
Technolas Perfect Vision
ACQUISITION by Bausch & Lomb Nov 2012
AcuFocus
ACQUISITION by Bausch & Lomb Jan 2023
Trukera Medical
ACQUISITION by Bausch & Lomb Jul 2024
Xiidra
ACQUISITION by Bausch & Lomb Jun 2023
Trukera Medical
ACQUISITION by Bausch & Lomb Jul 2024
Blink
ACQUISITION by Bausch & Lomb Jul 2023